Vivani Medical, Inc. (VANI)
USD 0.99
(-1.98%)
USD 0.99
(-1.98%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -26.96 Million USD | -26.95% |
| 2022 | -21.24 Million USD | -59.43% |
| 2021 | -13.32 Million USD | -44.14% |
| 2020 | -9.24 Million USD | 69.79% |
| 2019 | -30.59 Million USD | 12.14% |
| 2018 | -34.82 Million USD | -21.3% |
| 2017 | -28.7 Million USD | 13.55% |
| 2016 | -33.21 Million USD | -65.66% |
| 2015 | -20.04 Million USD | 5.59% |
| 2014 | -21.23 Million USD | -17.98% |
| 2013 | -17.99 Million USD | -12.33% |
| 2012 | -16.02 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -6.22 Million USD | -0.16% |
| 2024 Q2 | -5.68 Million USD | 8.77% |
| 2023 Q2 | -7 Million USD | -6.09% |
| 2023 Q3 | -7.14 Million USD | -2.01% |
| 2023 Q1 | -6.6 Million USD | 15.26% |
| 2023 FY | -26.96 Million USD | -26.95% |
| 2023 Q4 | -6.21 Million USD | 12.98% |
| 2022 Q3 | -5.44 Million USD | -33.2% |
| 2022 Q1 | -3.9 Million USD | -10.12% |
| 2022 FY | -21.24 Million USD | -59.43% |
| 2022 Q4 | -7.79 Million USD | -43.09% |
| 2022 Q2 | -4.08 Million USD | -4.61% |
| 2021 Q3 | -3.48 Million USD | -51.79% |
| 2021 Q4 | -3.54 Million USD | -1.81% |
| 2021 Q1 | -2.97 Million USD | -133.52% |
| 2021 FY | -13.32 Million USD | -44.14% |
| 2021 Q2 | -2.29 Million USD | 22.82% |
| 2020 Q1 | -8.9 Million USD | -9.57% |
| 2020 Q4 | -1.27 Million USD | 20.47% |
| 2020 Q3 | -1.6 Million USD | 48.59% |
| 2020 Q2 | -3.11 Million USD | 65.0% |
| 2020 FY | -9.24 Million USD | 69.79% |
| 2019 Q1 | -9.76 Million USD | -10.04% |
| 2019 FY | -30.59 Million USD | 12.14% |
| 2019 Q4 | -8.12 Million USD | -6.65% |
| 2019 Q3 | -7.61 Million USD | 9.74% |
| 2019 Q2 | -8.44 Million USD | 13.59% |
| 2018 Q3 | -8.54 Million USD | -6.99% |
| 2018 FY | -34.82 Million USD | -21.3% |
| 2018 Q1 | -9.76 Million USD | -31.43% |
| 2018 Q2 | -7.98 Million USD | 18.23% |
| 2018 Q4 | -8.87 Million USD | -3.87% |
| 2017 FY | -28.7 Million USD | 13.55% |
| 2017 Q1 | -7.55 Million USD | 27.24% |
| 2017 Q2 | -6.87 Million USD | 9.04% |
| 2017 Q3 | -6.74 Million USD | 1.79% |
| 2017 Q4 | -7.43 Million USD | -10.13% |
| 2016 Q1 | -5.82 Million USD | -6.29% |
| 2016 FY | -33.21 Million USD | -65.66% |
| 2016 Q4 | -10.38 Million USD | -22.17% |
| 2016 Q3 | -8.49 Million USD | 0.09% |
| 2016 Q2 | -8.5 Million USD | -46.14% |
| 2015 Q1 | -4.96 Million USD | 10.86% |
| 2015 FY | -20.04 Million USD | 5.59% |
| 2015 Q2 | -4.94 Million USD | 0.27% |
| 2015 Q4 | -5.47 Million USD | -17.46% |
| 2015 Q3 | -4.66 Million USD | 5.76% |
| 2014 Q4 | -5.56 Million USD | 1.49% |
| 2014 Q2 | -5.56 Million USD | -24.83% |
| 2014 Q1 | -4.45 Million USD | -2.78% |
| 2014 FY | -21.23 Million USD | -17.98% |
| 2014 Q3 | -5.64 Million USD | -1.55% |
| 2013 Q2 | -4.1 Million USD | 16.91% |
| 2013 FY | -17.99 Million USD | -12.33% |
| 2013 Q1 | -4.94 Million USD | 0.0% |
| 2013 Q4 | -4.33 Million USD | 5.94% |
| 2013 Q3 | -4.6 Million USD | -12.23% |
| 2012 FY | -16.02 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | -87.765% |
| Cerus Corporation | -30.05 Million USD | 10.275% |
| OrthoPediatrics Corp. | -25.76 Million USD | -4.653% |
| PetVivo Holdings, Inc. | -10.62 Million USD | -153.876% |
| Talis Biomedical Corporation | -66.81 Million USD | 59.642% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | -55.903% |
| Inogen, Inc. | -109.38 Million USD | 75.349% |
| Spectral AI, Inc. | -12.98 Million USD | -107.679% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 56.917% |
| CVRx, Inc. | -43.1 Million USD | 37.441% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -664.314% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | -116.97% |
| Orthofix Medical Inc. | -139.11 Million USD | 80.616% |
| Venus Concept Inc. | -28.3 Million USD | 4.748% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 50.091% |
| Bioventus Inc. | -81.72 Million USD | 67.005% |
| BrainsWay Ltd. | -4.92 Million USD | -447.29% |
| Envoy Medical, Inc. | -18.37 Million USD | -46.78% |
| electroCore, Inc. | -18.8 Million USD | -43.393% |
| IceCure Medical Ltd | -15.57 Million USD | -73.119% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 44.381% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | -56.156% |
| MaxCyte, Inc. | -48.29 Million USD | 44.171% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | -125.549% |
| Nexalin Technology, Inc. | -5.69 Million USD | -373.378% |
| PAVmed Inc | -68.79 Million USD | 60.804% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 52.327% |
| RxSight, Inc. | -50.08 Million USD | 46.162% |
| Sight Sciences, Inc. | -57.27 Million USD | 52.919% |
| SI-BONE, Inc. | -46.93 Million USD | 42.543% |
| TELA Bio, Inc. | -44.07 Million USD | 38.82% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 50.203% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 47.567% |
| LivaNova PLC | -68.49 Million USD | 60.634% |
| 908 Devices Inc. | -42.75 Million USD | 36.936% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 84.449% |
| Nemaura Medical Inc. | -9.59 Million USD | -181.025% |
| NeuroPace, Inc. | -27.17 Million USD | 0.769% |
| LENSAR, Inc. | -12.22 Million USD | -120.5% |
| Apyx Medical Corporation | -17.25 Million USD | -56.237% |
| Cutera, Inc. | -156.23 Million USD | 82.74% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | -213.401% |
| BioSig Technologies, Inc. | -28.51 Million USD | 5.426% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 69.232% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | -20.133% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | 124.178% |
| Axonics, Inc. | -26.05 Million USD | -3.485% |
| Outset Medical, Inc. | -169.77 Million USD | 84.117% |
| IRIDEX Corporation | -10 Million USD | -169.461% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 75.3% |
| IRadimed Corporation | 20.03 Million USD | 234.586% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -227.047% |
| INVO Bioscience, Inc. | -6.76 Million USD | -298.469% |
| Telesis Bio, Inc. | -35.15 Million USD | 23.286% |
| Viemed Healthcare, Inc. | 14.33 Million USD | 288.172% |
| Varex Imaging Corporation | 32.1 Million USD | 184.003% |
| Quipt Home Medical Corp. | 3.91 Million USD | 788.058% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -122.245% |
| Pulmonx Corporation | -61.93 Million USD | 56.462% |
| Dynatronics Corporation | -2.27 Million USD | -1086.293% |
| Modular Medical, Inc. | -17.52 Million USD | -53.831% |
| ReShape Lifesciences Inc. | -14.63 Million USD | -84.2% |
| Semler Scientific, Inc. | 22.25 Million USD | 221.158% |
| InMode Ltd. | 195.66 Million USD | 113.782% |
| Bruker Corporation | 436.9 Million USD | 106.172% |
| Cytosorbents Corporation | -31.2 Million USD | 13.599% |
| DexCom, Inc. | 597.7 Million USD | 104.511% |
| Align Technology, Inc. | 643.33 Million USD | 104.191% |
| Viveve Medical, Inc. | -21.55 Million USD | -25.11% |
| ZimVie Inc. | -30.93 Million USD | 12.845% |
| Movano Inc. | -29.69 Million USD | 9.178% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 3.16% |
| Nexalin Technology, Inc. | -5.69 Million USD | -373.378% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -664.314% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 88.438% |
| Profound Medical Corp. | -28.61 Million USD | 5.769% |
| Insulet Corporation | 220 Million USD | 112.257% |
| enVVeno Medical Corporation | -25.23 Million USD | -6.843% |
| Surmodics, Inc. | -5.64 Million USD | -377.679% |
| iCAD, Inc. | -7.68 Million USD | -250.696% |
| Nuwellis, Inc. | -17.63 Million USD | -52.95% |
| Biotricity, Inc. | -8.82 Million USD | -205.439% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 78.456% |
| Aethlon Medical, Inc. | -12.63 Million USD | -113.389% |
| InspireMD, Inc. | -21.14 Million USD | -27.536% |
| PAVmed Inc. | -68.79 Million USD | 60.804% |
| BIOLASE, Inc. | -17.93 Million USD | -50.332% |
| Beyond Air, Inc. | -63 Million USD | 57.202% |
| FONAR Corporation | 16.53 Million USD | 263.075% |
| AxoGen, Inc. | -21.46 Million USD | -25.641% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | 249.465% |
| Inari Medical, Inc. | -14.03 Million USD | -92.168% |
| UFP Technologies, Inc. | 57.66 Million USD | 146.762% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | -447.224% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | -327.624% |
| Tenon Medical, Inc. | -15.72 Million USD | -71.457% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | -260.784% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 36.859% |
| AdaptHealth Corp. | -598.4 Million USD | 95.494% |
| Sintx Technologies, Inc. | -13.35 Million USD | -101.864% |
| NanoVibronix, Inc. | -3.43 Million USD | -684.779% |
| Quanterix Corporation | -49.7 Million USD | 45.746% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | -122.245% |
| Sensus Healthcare, Inc. | -382 Thousand USD | -6958.901% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 91.938% |
| TransMedics Group, Inc. | -28.72 Million USD | 6.134% |
| ReWalk Robotics Ltd. | -23.61 Million USD | -14.2% |
| NeuroMetrix, Inc. | -7.15 Million USD | -277.053% |
| Hyperfine, Inc. | -48.11 Million USD | 43.957% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 58.532% |
| Biomerica, Inc. | -6.36 Million USD | -323.512% |
| Bone Biologics Corporation | -9.42 Million USD | -186.001% |
| AVITA Medical, Inc. | -40.4 Million USD | 33.258% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | -161.511% |
| Silk Road Medical, Inc | -59.27 Million USD | 54.506% |